Table 1.
Clinical and serological data for patients with APS whose samples were used in these experiments.
| APS patients | |
|---|---|
| Number | 18 |
| Age | 49.5 (±12) |
| Female | 13 |
| Male | 5 |
| Caucasian | 17 |
| Asian | 1 |
| SLE/APS | 8 |
| VT | 11 |
| VT PM | 6 |
| CAPS | 1 |
| LA | 17 |
| Mean aCL (GPLU) | 64 (SD 36) |
| Mean aB2GPI (GBU) | 54 (SD 44) |
| Mean aDI (GDIU) | 45 (SD 41) |
| aDI positive | 10 |
| aβ2GPI positive | 12 |
| aCL positive | 13 |
Patient data for those used to test for activity for D8S,D9G and WT protein. Note that cut-off for positivity in the aCL assay is >17GPLU, in the β2GPI assay it is >8GBU, and for DI positivity it is >10 GDIU. All cut off values were derived from 200 healthy patients.